Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP435404.RA2u-DFg-8jRv82EQVPlV38oX8eb0Rl8cm4vVwKeY_JRQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP435404.RA2u-DFg-8jRv82EQVPlV38oX8eb0Rl8cm4vVwKeY_JRQ130_assertion type Assertion NP435404.RA2u-DFg-8jRv82EQVPlV38oX8eb0Rl8cm4vVwKeY_JRQ130_head.
- NP435404.RA2u-DFg-8jRv82EQVPlV38oX8eb0Rl8cm4vVwKeY_JRQ130_assertion description "[Somatostatin analogues have been the treatment of choice in symptomatic patients with carcinoid tumors, but more recent studies have indicated a cytostatic effect of somatostatin analogues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP435404.RA2u-DFg-8jRv82EQVPlV38oX8eb0Rl8cm4vVwKeY_JRQ130_provenance.
- NP435404.RA2u-DFg-8jRv82EQVPlV38oX8eb0Rl8cm4vVwKeY_JRQ130_assertion evidence source_evidence_literature NP435404.RA2u-DFg-8jRv82EQVPlV38oX8eb0Rl8cm4vVwKeY_JRQ130_provenance.
- NP435404.RA2u-DFg-8jRv82EQVPlV38oX8eb0Rl8cm4vVwKeY_JRQ130_assertion SIO_000772 11790979 NP435404.RA2u-DFg-8jRv82EQVPlV38oX8eb0Rl8cm4vVwKeY_JRQ130_provenance.
- NP435404.RA2u-DFg-8jRv82EQVPlV38oX8eb0Rl8cm4vVwKeY_JRQ130_assertion wasDerivedFrom befree-20140225 NP435404.RA2u-DFg-8jRv82EQVPlV38oX8eb0Rl8cm4vVwKeY_JRQ130_provenance.
- NP435404.RA2u-DFg-8jRv82EQVPlV38oX8eb0Rl8cm4vVwKeY_JRQ130_assertion wasGeneratedBy ECO_0000203 NP435404.RA2u-DFg-8jRv82EQVPlV38oX8eb0Rl8cm4vVwKeY_JRQ130_provenance.